Journal Club E36: ImmunoSep: Can We Treat Sepsis Based on Which Immune Dysfunction a Patient Has? episode artwork

EPISODE · Dec 8, 2025 · 6 MIN

Journal Club E36: ImmunoSep: Can We Treat Sepsis Based on Which Immune Dysfunction a Patient Has?

from AZense Journal Club · host Azense Medical Education

Does phenotype-guided immunotherapy (anakinra for MALS, interferon-gamma for immunoparalysis) improve sepsis outcomes?

Episode metadata supplied by the publisher feed · Published Dec 8, 2025

Embed this episode

Ready to play

Journal Club E36: ImmunoSep: Can We Treat Sepsis Based on Which Immune Dysfunction a Patient Has?

0:00 6:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AZense Journal Club?

This episode is 6 minutes long.

When was this AZense Journal Club episode published?

This episode was published on December 8, 2025.

Can I download this AZense Journal Club episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!